Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.

ABSTRACT:

Background

Where resources are available, the World Health Organization recommends cervical cancer screening with human papillomavirus (HPV) DNA testing and subsequent treatment of HPV-positive women with timely cryotherapy. Newer technologies may facilitate a same-day screen-and-treat approach, but these testing systems are generally too expensive for widespread use in low-resource settings.

Methods

To assess the value of a hypothetical point-of-care HPV test, we used a mathematical simulation model of the natural history of HPV and data from the START-UP multi-site demonstration project to estimate the health benefits and costs associated with a shift from a 2-visit approach (requiring a return visit for treatment) to 1-visit HPV testing (i.e., screen-and-treat). We estima

SUBMITTER: Campos NG 

PROVIDER: S-EPMC5702206 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature